Ticker
ATAICompany Name
ATAI LIFE SCIENCES NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 9.22M | $ 143.74M | $ 152.95M |
3/31/2025 | $ 26.67M | $ 152.05M | $ 178.72M |
12/31/2024 | $ 24.71M | $ 116.3M | $ 141M |
9/30/2024 | $ 23.81M | $ 145.72M | $ 169.53M |
6/30/2024 | $ 19.63M | $ 167.89M | $ 187.52M |
3/31/2024 | $ 20.81M | $ 222.54M | $ 243.35M |
12/31/2023 | $ 19.14M | $ 242.96M | $ 262.1M |
9/30/2023 | $ 16.67M | $ 266.28M | $ 282.94M |
6/30/2023 | $ 16.7M | $ 212.55M | $ 229.25M |
3/31/2023 | $ 16.71M | $ 236.82M | $ 253.53M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for ATAI LIFE SCIENCES NV is calculated as follows: Debt [ $ 2.18M ] + Equity [ $ 90.82M ]
(=) Inv. Capital [ $ 93M ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 760.31M |
median | $ 303.21M |
std | $ 1B |